Source: Annual Congress 2001 - New treatments for asthma and COPD: PDE4 inhibitors and anti-IGE
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Omalizumab improves asthma-specific quality of life in patients with severe allergic asthma. Eur Respir J 2001; 16: Suppl. 31, 348

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of omalizumab in improving quality of life in patients with ‘steroid-resistant‘ asthma and severe allergic rhinitis Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Omalizumab significantly improves quality of life in patients with severe persistent allergic asthma: a pooled analysis Source: Eur Respir J 2005; 26: Suppl. 49, 49s Year: 2005 Improvement of control and quality of life in severe allergic asthmatics patients treated with omalizumab Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Improvements in asthma control and quality of life with omalizumab in allergic (IgE-mediated) asthma patients Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 The effect of allergic rhinitis on quality of life and sleep quality in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 443s Year: 2006 The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma Source: Eur Respir J 2002; 20: 1088-1094 Year: 2002 Improving effect of fudosteine on sputum symptoms and health-related quality of life of patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 115s Year: 2006 Quality of life in children with asthma associated with allergic rhinitis Source: Annual Congress 2009 - How viruses, allergic rhinitis and air pollution affect childhood asthma Year: 2009 Quality of life in patients with asthma or rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 120s Year: 2002 Evaluation of asthma knowledge and quality of life in adult patients with asthma Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011 Patients with asthma and comorbid allergic rhinitis: Is optimal quality of life achievable in real life? Source: Annual Congress 2011 - Asthma: risk factors and comorbidities Year: 2011 Assesment of quality of life in patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 284s Year: 2004 Respiratory symptoms are associated with impaired health-related quality of life in subjects with neither asthma nor COPD Source: Annual Congress 2009 - Risk factors for asthma and pneumonia Year: 2009 Adding omalizumab to high-dose ICS and LABA significantly improves quality of life in patients with severe persistent allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 440s Year: 2006 Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey Source: Eur Respir J 2013; 42: 1224-1233 Year: 2013 Omalizumab in severe asthma: real life study Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Monitoring asthma in childhood: symptoms, exacerbations and quality of life Source: Eur Respir Rev 2015; 24: 187-193 Year: 2015 Improvement in rhinosinusitis health related quality of life in patients with severe eosinophilic asthma Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Corticosteroid-dependent bronchial asthma: control of symptoms and quality of life Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003